Amylin Pharmaceuticals: Wikis

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Categories: Pharmaceutical companies of the United States | Companies in the NASDAQ Biotechnology Index | Companies based in San Diego, California | Companies established in 1987

Encyclopedia

Updated live from Wikipedia, last check: May 29, 2012 15:07 UTC (36 seconds ago)

From Wikipedia, the free encyclopedia

Amylin Pharmaceuticals

Type	Public (NASDAQ: AMLN)
Founded	1987
Headquarters	San Diego, California, USA
Key people	Daniel M. Bradbury^[1]
Industry	Biotechnology
Products	Symlin (pramlintide) Byetta (exenatide)
Employees	1,900 [1]
Website	www.amylin.com

Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces two drugs, Symlin (pramlintide acetate) and Byetta (exenatide). Amylin also is working on producing a drug based on Leptin.[2].